Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0001697616-26-000004

Chief Financial Officer sold 1,991 shares at $16.82 ($33,489)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lucera Erick · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-11-13 Sale : show line 1 in the form 10b5-1 −1,991 $16.82 $33,489 117,775 D
Open-market sales · 1,991 sh · avg $16.82 · $33,489
Loading xslF345X06/ownership.xml…